Published in Ann Surg on October 01, 1993
Induction of transplantation tolerance in non-human primate preclinical models. Philos Trans R Soc Lond B Biol Sci (2005) 1.02
Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-beta 1. Ann Surg (1994) 0.79
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature (1985) 11.55
Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol (1982) 8.88
Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med (1979) 7.20
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Monoclonal cytolytic T-cell lines. J Exp Med (1979) 5.28
"Infectious" transplantation tolerance. Science (1993) 4.98
Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J Cell Physiol (1989) 3.58
Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science (1992) 2.43
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol (1990) 1.96
A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol (1986) 1.79
Rabbit tumor necrosis factor: mechanism of action. Infect Immun (1981) 1.62
Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J Immunol (1989) 1.51
Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells. Proc Natl Acad Sci U S A (1989) 1.50
Evolutionary relationship between the T3 chains of the T-cell receptor complex and the immunoglobulin supergene family. Proc Natl Acad Sci U S A (1987) 1.31
Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med (1991) 1.29
Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med (1990) 1.28
Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol (1990) 1.26
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
Molecular cloning of the murine homologue of CD2. Homology of the molecule to its human counterpart T11. J Immunol (1988) 1.16
Regulation of D-3 phosphoinositides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigens. Eur J Immunol (1992) 1.09
Cardiac transplantation in mice. I. Factors influencing the take and survival of heterotopic grafts. Transplantation (1971) 1.06
Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation (1990) 1.06
TRANSPLANTATION OF CARDIAC TISSUE INTO THE MOUSE EAR. Am J Anat (1963) 1.02
Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation (1991) 1.01
Antibody 12-15 cross-reacts with mouse Fc gamma receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 protein. Eur J Immunol (1989) 1.01
Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. J Immunol (1989) 0.99
Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies. J Immunol (1987) 0.97
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent. Transplantation (1986) 0.96
OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release. Transplantation (1991) 0.96
Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. Transplantation (1991) 0.95
Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation (1992) 0.93
Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J Immunol (1992) 0.93
Cytokine mRNA levels in antigen-stimulated peripheral blood mononuclear cells. Eur J Immunol (1989) 0.93
Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation (1992) 0.90
Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J Immunol (1992) 0.89
Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigens. Eur J Immunol (1989) 0.88
Anti-TNF abrogates the cytokine-related anti-CD3 induced syndrome. Transplant Proc (1991) 0.88
Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids. Transplantation (1990) 0.88
OKT3-induced cytokine mRNA expression in human peripheral blood mononuclear cells measured by polymerase chain reaction. Scand J Immunol (1992) 0.85
Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies. Transplantation (1991) 0.81
The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation. Transplantation (1991) 0.81
Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects. Transplantation (1993) 0.80
Direct activation of murine resting T cells by con A or anti-CD3 Ig. J Mol Cell Immunol (1989) 0.79
Suppression of the humoral response to anti-CD3 monoclonal antibody. Transplantation (1989) 0.79
Subpopulations of fetal thymocytes defined by expression of T cell receptor/CD3 and IL-2 receptor. CD3 and IL-2 receptor alpha-chain are expressed on reciprocal cell populations. J Immunol (1991) 0.76
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 23.49
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med (1995) 8.23
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (2000) 5.55
The nucleotide sequence of the cloned rpoD gene for the RNA polymerase sigma subunit from E coli K12. Nucleic Acids Res (1981) 5.52
Crystal structure of TFIID TATA-box binding protein. Nature (1992) 4.85
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell (2001) 4.58
Obesity-related glomerulopathy: an emerging epidemic. Kidney Int (2001) 3.98
An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem (2000) 3.44
Phenotypic diversity and ecosystem functioning in changing environments: a theoretical framework. Proc Natl Acad Sci U S A (2001) 3.13
The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium. Mol Microbiol (1995) 3.11
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J Cell Biol (1994) 2.95
kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood (1994) 2.94
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Signal transduction by the TCR for antigen. Curr Opin Immunol (2000) 2.87
mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol (1996) 2.78
Both lumenal and cytosolic gating of the aqueous ER translocon pore are regulated from inside the ribosome during membrane protein integration. Cell (1997) 2.71
NMR structure of the histidine kinase domain of the E. coli osmosensor EnvZ. Nature (1998) 2.69
The dynamics of cocirculating influenza strains conferring partial cross-immunity. J Math Biol (1997) 2.69
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science (1995) 2.68
Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59
Histidine kinases: diversity of domain organization. Mol Microbiol (1999) 2.47
Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene (1994) 2.47
Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med (1995) 2.44
Shotgun optical maps of the whole Escherichia coli O157:H7 genome. Genome Res (2001) 2.43
Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature (1997) 2.41
Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol (1995) 2.25
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene (2001) 2.25
Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int (2006) 2.23
PartsList: a web-based system for dynamically ranking protein folds based on disparate attributes, including whole-genome expression and interaction information. Nucleic Acids Res (2001) 2.23
Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes (2001) 2.19
Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology (1996) 2.07
Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther (1997) 2.07
Completely diverted tube ileostomy compared with loop ileostomy for protection of low colorectal anastomosis: a pilot study. Colorectal Dis (2014) 2.06
Beyond synexpression relationships: local clustering of time-shifted and inverted gene expression profiles identifies new, biologically relevant interactions. J Mol Biol (2001) 2.03
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science (2000) 2.03
Evaluation of three hollow-fiber membrane oxygenators without integrated arterial filters for neonatal cardiopulmonary bypass. Perfusion (2011) 2.02
Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost (2007) 2.02
P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest (1995) 2.02
Ribose facilitates thallium-201 redistribution in patients with coronary artery disease. J Nucl Med (1991) 2.00
The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol (1996) 1.97
Injecting drug use and HIV infection in southwest China. AIDS (1994) 1.91
The cotranslational integration of membrane proteins into the phospholipid bilayer is a multistep process. Cell (1996) 1.88
Lipid composition and lipid metabolism of Spiroplasma citri. J Bacteriol (1976) 1.87
Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology (2001) 1.84
Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J (2004) 1.79
Mild hypothermia via selective head cooling as neuroprotective therapy in term neonates with perinatal asphyxia: an experience from a single neonatal intensive care unit. J Perinatol (2006) 1.79
An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A (1998) 1.76
Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant (2015) 1.76
Phosphatase activity of histidine kinase EnvZ without kinase catalytic domain. Proc Natl Acad Sci U S A (2000) 1.75
Mitochondrial COII sequences and modern human origins. Mol Biol Evol (1993) 1.73
Still embedded together binding to membranes regulates Bcl-2 protein interactions. Oncogene (2010) 1.72
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev (1995) 1.69
New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant (2006) 1.68
US of soft-tissue foreign bodies and associated complications with surgical correlation. Radiographics (2001) 1.66
A TRP homolog in Saccharomyces cerevisiae forms an intracellular Ca(2+)-permeable channel in the yeast vacuolar membrane. Proc Natl Acad Sci U S A (2001) 1.63
Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol (2000) 1.61
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet (1998) 1.58
Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet (2000) 1.57
Functional neuroanatomy of spatial working memory in children. Dev Psychol (2000) 1.57
Renal aspergilloma: an unusual cause of infection in a patient with the acquired immunodeficiency syndrome. Am J Med (1992) 1.56
Death as a complication of peripherally inserted central catheters in neonates. J Pediatr (2001) 1.56
Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest (1998) 1.55
Medium for Screening Leuconostoc oenos Strains Defective in Malolactic Fermentation. Appl Environ Microbiol (1989) 1.54
Effect of whole body vibration (WBV) therapy on bone density and bone quality in osteopenic girls with adolescent idiopathic scoliosis: a randomized, controlled trial. Osteoporos Int (2012) 1.53
Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene (2010) 1.53
Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women. Brain Behav Immun (2008) 1.53
A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet (2000) 1.51
Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke (1999) 1.51
Change in failure stress on the southern san andreas fault system caused by the 1992 magnitude = 7.4 landers earthquake. Science (1992) 1.51
African Americans and participation in clinical trials: differences in beliefs and attitudes by gender. Contemp Clin Trials (2006) 1.51
Percutaneous trans-hepatic cholangioscopy and lithotripsy in the treatment of intrahepatic stones: a study with 5 year follow-up. Gastrointest Endosc (1995) 1.50
Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation. Curr Med Res Opin (2009) 1.50
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Br J Cancer (2005) 1.48
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene (2000) 1.47
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J Med Chem (1999) 1.47
Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. Anticancer Res (2000) 1.46
Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem (1997) 1.45
Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med (1994) 1.45
Role of data aggregation in biosurveillance detection strategies with applications from ESSENCE. MMWR Morb Mortal Wkly Rep (2004) 1.42
Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer (2000) 1.42
Subinsular vascular lesions: an analysis of 119 consecutive autopsied brains. Eur J Neurol (2007) 1.40
A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther (2006) 1.40
Hispanic/white differences in dietary fat intake among low educated adults and children. Prev Med (1994) 1.40
A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity. Int J Geriatr Psychiatry (2012) 1.39
Viremia and serological responses in adult chickens infected with western equine encephalomyelitis and St. Louis encephalitis viruses. J Am Mosq Control Assoc (1994) 1.38
Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther (1998) 1.38
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant (2006) 1.37
Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes (1998) 1.37
Hispanic versus white smoking patterns by sex and level of education. Am J Epidemiol (1995) 1.36
Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry (2011) 1.36
Generalized low areal and volumetric bone mineral density in adolescent idiopathic scoliosis. J Bone Miner Res (2000) 1.34
Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev (2006) 1.34
Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer (1994) 1.33
Stat3 activation in human endometrial and cervical cancers. Br J Cancer (2007) 1.31